Severity
Moderate
FDA Drug recall · Reported December 24, 2025
Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint
Sun Pharma /Taro recalled Ciclopirox Shampoo, 1%, 120 mL, Rx only, Mfg by: Taro Pharmaceuticals Inc., Ontario, Cana… - a moderate-severity action.
Ciclopirox Shampoo, 1%, 120 mL, Rx only, Mfg by: Taro Pharmaceuticals Inc., Ontario, Cana… was recalled by Sun Pharma /Taro in December 24, 2025. Reason: Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint. Check the official notice for the remedy. Verify recall #D-0240-2026 with the FDA Drug before acting.
The recall
Sun Pharma /Taro issued this moderate-severity FDA Drug recall-Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint.
Sourced from official FDA Drug enforcement records. Verify recall #D-0240-2026 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0240-2026) was formally reported on December 24, 2025, with the manufacturer initiating the action on December 9, 2025. It is classified under Moderate severity (Class II), with a current status of Ongoing. Sun Pharma /Taro is listed as the recalling firm, operating out of Hawthorne, NY. Federal records list the affected scope as 17,664 units.
The documented reason for this recall is: Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint Distribution data in the federal record shows the product reached: Nationwide within the United States. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 1,360 cosmetics & personal care recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
17,664 units
Related Recalls
6
3 from same agency
Ciclopirox Shampoo, 1%, 120 mL, Rx only, Mfg by: Taro Pharmaceuticals Inc., Ontario, Canada; Dist. by: Taro Pharmaceuticals USA, Inc., NY 10532. NDC 51672-1351-08
Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | D-0240-2026 |
| Date reported | December 24, 2025 |
| Date initiated | December 9, 2025 |
| Recalling firm | Sun Pharma /Taro |
| Firm location | Hawthorne, NY |
| Affected scope | 17,664 units |
| Distribution | Nationwide within the United States |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-06-04
PS Seasoning & Spices, Inc. · 2026-05-27
Fontana Flavors, Inc · 2026-05-27
Wisconsin Pharmacal Company · 2026-05-27
SUN PHARMACEUTICAL INDUSTRIES INC · 2026-04-22
Compare this recall with Tiny Land Children's Play Tents Recalled Due to Risk of Inj… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported December 24, 2025. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.